---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-24-000090"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:27:18.607569+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics Q3 record revenue $54.6M (+37% YoY); raises FY guidance to $202-204M

## Summary
- Revenue $54.6M (+37% YoY); domestic up 45%, international up 12%.
- Net loss $7.9M ($0.34/shr) vs $4.6M ($0.20) YoY; $3.2M one-time refinancing expense.
- Adjusted EBITDA $4.0M vs $3.6M in Q3 2023; gross margin 73% vs 77%.
- Raised FY 2024 revenue guidance to $202-204M from $200-203M; reaffirmed Adj. EBITDA $8-9M.
- Helped record >33,000 children (+50% YoY); Trauma & Deformity +31%, Scoliosis +52%.

## SEC filing metadata
- accession: 0001425450-24-000090
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545024000090/0001425450-24-000090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545024000090/kids-20241106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-24-000090
- JSON: https://secwatch.observer/filing/0001425450-24-000090.json
- Plain text: https://secwatch.observer/filing/0001425450-24-000090.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.